Companies / Avilar Therapeutics
Avilar Therapeutics
United States
Avilar Therapeutics is developing novel degraders of extracellular proteins as future standard of care medicines for the treatment of multiple serious diseases.
Avilar Therapeutics, based in United States, has 4 investors on file, among them Astellas Venture Management, Medical Excellence Capital and RA Capital. Its site was last checked 13 Nov 2026: site answers.
SEC Form D filings
2 filingsFiled by Avilar Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Corporate VC |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Avilar Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Astellas Venture Management adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/avilar-tx.com/investors
# also
GET /v1/companies/avilar-tx.com
GET /v1/companies/avilar-tx.com/news